Imetelstat Sodium FDA approval date

The FDA approved Imetelstat Sodium (GRN163L) on 6 Jun 2024.

FDA approval date
6 Jun 2024

Drug identity checked against registry records

Also recorded as GRN163L

Included trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2024-06-06DayImetelstat SodiumFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA217779", "applicant_as_listed_by_fda": "GERON", "brand_names": ["RYTELO"], "active_ingredients": ["IMETELSTAT SODIUM"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20240606", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026